| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/19/1999 | EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS |
| 05/19/1999 | CN1217028A Method of modulating melanin synthesis |
| 05/19/1999 | CN1217027A Parapoxviruses contg. foreign DNA, their prodn. and their use in vacciens |
| 05/19/1999 | CN1217024A Chemokine alpha 2 |
| 05/19/1999 | CN1216995A Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 05/19/1999 | CN1216994A Apoptosis inducing molecule II |
| 05/19/1999 | CN1216993A Alkyl-4-silyl-phenols and esters thereof as anti-atherosclerotic agent |
| 05/19/1999 | CN1216991A Mesylate dihydrate salts of 5-(2-(4-(1,2-benzi sothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one |
| 05/19/1999 | CN1216990A Mesylate trihydrate salt of 5-(2-(4-(1,2-benzi isothiazol-3-yl)-1-piperazinyl) ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one |
| 05/19/1999 | CN1216989A Process for preparing magnesium salt of substituted sulphinyl heterocycle |
| 05/19/1999 | CN1216986A Isoxazole derivatives |
| 05/19/1999 | CN1216981A 3-alkoxypyridine-2-carboxylic acid amide esters, their prepn. and their use as drugs |
| 05/19/1999 | CN1216980A Triaryl compounds |
| 05/19/1999 | CN1216978A New vitamin-D derivatives with carbo- or heterocyclic substitutents at C-25, process for the prodn. intermediate products and their use for producing medicaments |
| 05/19/1999 | CN1216923A Inclusion complexes of aryl-heterocyclic salts |
| 05/19/1999 | CN1216921A Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
| 05/19/1999 | CN1216920A Acyl urea compounds for treatment of coccidioidomycosis in warmblooded animals |
| 05/19/1999 | CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them |
| 05/19/1999 | CN1216763A Sulfamine sbstituted benzodihydrofuran, method for preparing same, use as medicine, medicine prepns. contg. same |
| 05/19/1999 | CN1216762A 2-(arylphenyl) amino-imidazoline derivatives |
| 05/19/1999 | CN1216702A Compound prothiphenyl imidazole emulsion for repelling and curing animal endoparasites and ectoparasite, and method for preparing same |
| 05/19/1999 | CN1216701A New use of sinomenine |
| 05/19/1999 | CN1216700A Coolant powders |
| 05/19/1999 | CN1216685A Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing |
| 05/19/1999 | CN1043424C Quaternary nitrogen contg. phosphonate compounds, pharmaceutical compositions and pharmaceutical use |
| 05/19/1999 | CN1043423C New phosphonosuccinic acid derivatives, process for preparing same and pharmaceutical compositions contg. same |
| 05/19/1999 | CN1043422C Method for preparing polyhydroxycyclopentane derivatives |
| 05/19/1999 | CN1043405C Method for prepn. of pharmaceutical compositions contg. heterocyclic amide derivatives |
| 05/18/1999 | US5905156 Potassium channel activators and bronchodilators |
| 05/18/1999 | US5905149 Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors |
| 05/18/1999 | US5905089 Useful in suppressing early proinflammatory cytokines and in ameliorating septic shock and other severe inflammatory disorders |
| 05/18/1999 | US5905088 Skin disorders, rheumatic diseases, respiratory system or cardiovascular disorders and opthalmological disorders |
| 05/18/1999 | US5905086 Remedy for anxiety neurosis |
| 05/18/1999 | US5905084 5-HTIF -agonists effective in treating migraine |
| 05/18/1999 | US5905083 Method of treating rheumatoid arthritis |
| 05/18/1999 | US5905082 Crystalline oxathiolane derivatives |
| 05/18/1999 | US5905081 Topical formulations of azathioprine to treat inflammatory bowel disorders |
| 05/18/1999 | US5905080 Central nervous system, psychological, eating disorders; cognition activators, parkinson*s disease |
| 05/18/1999 | US5905079 Antiepileptic, antiischemic agents; nervous system, and brain disorders |
| 05/18/1999 | US5905078 Treatment of neurohormonal imbalance |
| 05/18/1999 | US5905077 Inhibitors of HIV protease useful for the treatment of AIDS |
| 05/18/1999 | US5905076 Treatment of muscular dystrophy, arthritis, myocardial infarction, alzheimer's disease, bacterial infection, common cold, osteoporosis or cancer metastasis |
| 05/18/1999 | US5905075 Chromium nicotinate compositions and uses thereof |
| 05/18/1999 | US5905074 Skin disorders, antitumor agents, vitamin d derivatives |
| 05/18/1999 | US5905073 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 05/18/1999 | US5905070 5--Caboxamido or 5--fluoro!-- 2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides |
| 05/18/1999 | US5905069 Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 05/18/1999 | US5904938 Anticoagulants using nitric oxide by breathing |
| 05/18/1999 | US5904937 Taste masked pharmaceutical compositions |
| 05/18/1999 | US5904932 Topical preparation containing a suspension of solid lipid particles |
| 05/18/1999 | US5904931 Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide |
| 05/18/1999 | US5904930 Hydroxytamoxifen derivatives in solutions |
| 05/18/1999 | US5904926 Weight loss compound and method of using |
| 05/18/1999 | US5904923 Methods for preparing pharmaceutical compositions and using same to treat drug addiction |
| 05/18/1999 | US5904921 Stabilized compositions of superoxide dismutase obtained from germinated plant seeds |
| 05/18/1999 | US5904144 Method for delivering a biologically active molecule to the eye |
| 05/18/1999 | CA2179264C 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 05/18/1999 | CA2161284C Novel o-arylmethyl n-thioacyl hydroxylamines, processes for their preparation and pharmaceutical compositions containing them |
| 05/18/1999 | CA2158952C 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists |
| 05/18/1999 | CA2144509C Skin-conditioning composition, its application and manufacture |
| 05/18/1999 | CA2141436C Treatment of alzheimer's disease and modulation of immune system with delta-5-androstenes |
| 05/18/1999 | CA2140639C Iodine/resin disinfectant and a procedure for the preparation thereof |
| 05/18/1999 | CA2109744C 1-phenylbicyclo¬2.2.2|octane derivatives, a process for their preparation and pharmaceutical compositions holding same |
| 05/18/1999 | CA2040884C Process for the preparation of 1-(2,3,4-trimethoxybenzyl) piperazine by reductive amination |
| 05/18/1999 | CA1340543C Pharmaceutically active compounds |
| 05/14/1999 | WO1999023237A1 Transfecting peptide vector, composition containing same and applications |
| 05/14/1999 | WO1999023227A2 Hyaluronan synthase gene and uses thereof |
| 05/14/1999 | WO1999023217A1 A novel gene and uses therefor |
| 05/14/1999 | WO1999023208A2 RIBOZYMES TARGETED TO IL-15 mRNA |
| 05/14/1999 | WO1999023108A1 Inducible phosphofructokinase and the warburg effect |
| 05/14/1999 | WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth |
| 05/14/1999 | WO1999023104A2 Antitumour uridine analogues |
| 05/14/1999 | WO1999023097A1 Substituted porphyrins |
| 05/14/1999 | WO1999023096A1 Phthalocyanine analogs |
| 05/14/1999 | WO1999023092A2 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them |
| 05/14/1999 | WO1999023091A1 Aromatic heterocyclic compounds as anti-inflammatory agents |
| 05/14/1999 | WO1999023087A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors |
| 05/14/1999 | WO1999023082A1 AMINOTHIAZOLE DERIVATIVES USEFUL IN THE PREPARATION OF β-LACTAM ANTIBIOTICS |
| 05/14/1999 | WO1999023078A2 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists |
| 05/14/1999 | WO1999023077A1 Indazole bioisostere replacement of catechol in therapeutically active compounds |
| 05/14/1999 | WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | WO1999023075A1 Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents |
| 05/14/1999 | WO1999023073A1 Biphenyl derivatives as pharmaceuticals |
| 05/14/1999 | WO1999023072A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 05/14/1999 | WO1999023063A1 Substituted anilides |
| 05/14/1999 | WO1999023010A1 Methods and compositions for treating dermatoses |
| 05/14/1999 | WO1999022802A1 Method and apparatus for applying 5-aminolevulinic acid |
| 05/14/1999 | WO1999022745A1 Cross-linked copolymers containing aminophosphonium groups for medical applications |
| 05/14/1999 | WO1999022744A1 Use of aliphatic polyamines for reducing oxalate |
| 05/14/1999 | WO1999022743A1 Poly(diallylamine)-based phosphate binders |
| 05/14/1999 | WO1999022742A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 05/14/1999 | WO1999022741A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/14/1999 | WO1999022740A1 Disaccharide derivatives for treating hyperglycaemia |
| 05/14/1999 | WO1999022739A1 Medicinal steroid compound composition |
| 05/14/1999 | WO1999022738A1 Compositions of lipid lowering agents |
| 05/14/1999 | WO1999022737A1 Use of methylnaltrexone and related compounds |
| 05/14/1999 | WO1999022736A1 Use of quinapril for treating myocardial ischemia and angina |
| 05/14/1999 | WO1999022734A1 Novel metal complexes |
| 05/14/1999 | WO1999022733A1 Novel metal complexes |
| 05/14/1999 | WO1999022732A1 Novel metal complexes |